{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:20:33Z","timestamp":1783405233369,"version":"3.54.6"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Transcatheter ablation (TCA) is an established treatment for atrial fibrillation (AF); however, the impact of age on procedural safety and ultra-early arrhythmic outcomes remains incompletely understood, particularly in real-world clinical settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the association between age and early procedural safety and ultra-early arrhythmic outcomes following AF ablation in an unselected real-world cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 217 consecutive patients (mean age 67 \u00b1 9 years) who underwent transcatheter ablation for atrial fibrillation between January 2022 and December 2023 at a single tertiary center. Age was analyzed using three predefined cutoffs (&amp;lt; 65, &amp;lt; 70, and &amp;lt; 80 years) and as a continuous variable. Multivariable logistic regression analyses were performed to assess the independent association between age and procedural safety and ultra-early arrhythmic outcomes. The primary safety endpoint was a composite of pericardial effusion and\/or cardiac tamponade confirmed by echocardiography, periprocedural bleeding requiring medical intervention or blood transfusion, stroke or transient ischemic attack (TIA), acute coronary events, cardiovascular or procedure-related death. The secondary arrhythmic endpoint was a composite of atrial fibrillation recurrence and AF persistence within 48 h. Both the composite endpoint and its individual components were evaluated in covariate-adjusted models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      No significant differences in early complications or arrhythmic outcomes were observed across the predefined age cutoffs. Multivariable logistic regression analysis showed that age was not independently associated with procedural safety (OR 0.99; 95% CI 0.93\u20131.06;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.812), AF recurrence (OR 1.01; 95% CI 0.97\u20131.05;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.77), or AF persistence (OR 1.00; 95% CI 0.96\u20131.05;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.91).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this real-world, single-center cohort, age was not independently associated with procedural safety or ultra-early arrhythmic outcomes following AF ablation. These findings suggest that chronological age alone may not be a major determinant of ultra-early procedural outcomes in appropriately selected patients undergoing AF ablation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1831225","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:45:27Z","timestamp":1783403127000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronological age was not independently associated with ultra-early safety or arrhythmic outcomes after contemporary atrial fibrillation ablation: a real-world single-center study"],"prefix":"10.3389","volume":"13","author":[{"given":"Gennaro","family":"De Rosa","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Advanced Biomedical Sciences, University of NaPles Federico II","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Giuggia","sequence":"additional","affiliation":[{"name":"Ciri\u00e8 Hospital","place":["Ciri\u00e8, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Peyracchia","sequence":"additional","affiliation":[{"name":"Ciri\u00e8 Hospital","place":["Ciri\u00e8, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Peddis","sequence":"additional","affiliation":[{"name":"Ciri\u00e8 Hospital","place":["Ciri\u00e8, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Di Summa","sequence":"additional","affiliation":[{"name":"Ciri\u00e8 Hospital","place":["Ciri\u00e8, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pelissero","sequence":"additional","affiliation":[{"name":"Ciri\u00e8 Hospital","place":["Ciri\u00e8, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Trapani","sequence":"additional","affiliation":[{"name":"Ciri\u00e8 Hospital","place":["Ciri\u00e8, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ugliano","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, University of Naples Federico II","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fiore","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Unit, Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research (CISI), Interdepartmental Center of Clinical and Translational Sciences (CIRCET), Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Corazzelli","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Presidio Ospedaliero \u201cSanta Maria Delle Grazie\u201d","place":["Pozzuoli, Italy"]},{"name":"Department of Human Neurosciences, Sapienza University of Rome","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Plinio","family":"Cirillo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Advanced Biomedical Sciences, University of NaPles Federico II","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Senatore","sequence":"additional","affiliation":[{"name":"Ciri\u00e8 Hospital","place":["Ciri\u00e8, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European association for cardio.","volume":"45","author":"Gelder","year":"2024","journal-title":"Eur Heart J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons.","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure.","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the cabana randomized clinical trial.","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/j.cjca.2024.08.263","article-title":"Catheter ablation for atrial fibrillation in elderly patients: an updated meta-analysis of comparative studies.","volume":"40","author":"Boehmer","year":"2024","journal-title":"Can J Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40119-019-00158-2","article-title":"Catheter ablation of atrial fibrillation: state of the art and future perspectives.","volume":"9","author":"Rottner","year":"2020","journal-title":"Cardiol Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1540-8167.2012.02293.x","article-title":"Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes.","volume":"23","author":"Santangeli","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation.","volume":"374","author":"Kuck","year":"2016","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/europace\/euw080","article-title":"Results from a multicentre comparison of cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: is cryoablation more reproducible?","volume":"19","author":"Providencia","year":"2017","journal-title":"Europace"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"Von Elm","year":"2007","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the cabana randomized clinical trial.","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jacc.2011.08.068","article-title":"Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation.","volume":"59","author":"Shah","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1540-8159.2011.03256.x","article-title":"Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation.","volume":"35","author":"Andrade","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"638","DOI":"10.4330\/wjc.v8.i11.638","article-title":"Mechanisms and clinical significance of early recurrences of atrial arrhythmias after catheter ablation for atrial fibrillation.","volume":"8","author":"Liang","year":"2016","journal-title":"World J Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1071950","DOI":"10.3389\/fcvm.2023.1071950","article-title":"Blanking period antiarrhythmic drugs after catheter ablation for atrial fibrillation: a meta-analysis of randomized controlled trials.","volume":"10","author":"Chen","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/eurheartj\/eht194","article-title":"Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy.","volume":"34","author":"Kottkamp","year":"2013","journal-title":"Eur Heart J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jacc.2015.06.1313","article-title":"Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications.","volume":"66","author":"Dzeshka","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.hrthm.2012.07.016","article-title":"The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study.","volume":"9","author":"Reddy","year":"2012","journal-title":"Heart Rhythm"},{"key":"B20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1056\/NEJMc1707247","article-title":"Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation.","volume":"377","author":"Calkins","year":"2017","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1093\/eurheartj\/ehv177","article-title":"Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.","volume":"36","author":"Cappato","year":"2015","journal-title":"Eur Heart J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/ageing\/afy180","article-title":"Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis.","volume":"48","author":"Wilkinson","year":"2019","journal-title":"Age Ageing"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s10840-025-02015-w","article-title":"Correlation between diagnosis-to-ablation time and atrial fibrillation recurrence: a systematic review and meta-analysis.","volume":"68","author":"Hassan","year":"2025","journal-title":"J Interv Card Electrophysiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/ejh.70155","article-title":"Oral anticoagulation after atrial fibrillation ablation: an updated systematic review and meta-analysis of 267 443 patients.","volume":"116","author":"Matteucci","year":"2026","journal-title":"Eur J Haematol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.3390\/jcm14082741","article-title":"Impact of ablation energy sources on perceived quality of life and symptom in atrial fibrillation patients: a comparative study.","volume":"14","author":"Matteucci","year":"2025","journal-title":"J Clin Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1831225\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:45:27Z","timestamp":1783403127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1831225\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":25,"alternative-id":["10.3389\/fmed.2026.1831225"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1831225","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"article-number":"1831225"}}